These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 18790021)

  • 1. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
    Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
    Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease.
    Lanciego JL; López IP; Rico AJ; Aymerich MS; Pérez-Manso M; Conte L; Combarro C; Roda E; Molina C; Gonzalo N; Castle M; Tuñón T; Erro E; Barroso-Chinea P
    Brain Res Bull; 2009 Feb; 78(2-3):55-9. PubMed ID: 18790023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.
    Jouve L; Salin P; Melon C; Kerkerian-Le Goff L
    J Neurosci; 2010 Jul; 30(29):9919-28. PubMed ID: 20660274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
    Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
    Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia.
    Bacci JJ; Kachidian P; Kerkerian-Le Goff L; Salin P
    J Neuropathol Exp Neurol; 2004 Jan; 63(1):20-31. PubMed ID: 14748558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.
    Stefani A; Peppe A; Pierantozzi M; Galati S; Moschella V; Stanzione P; Mazzone P
    Brain Res Bull; 2009 Feb; 78(2-3):113-8. PubMed ID: 18812214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus.
    Bacci JJ; Absi el H; Manrique C; Baunez C; Salin P; Kerkerian-Le Goff L
    Eur J Neurosci; 2004 Dec; 20(12):3331-41. PubMed ID: 15610165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson's disease.
    Kerkerian-Le Goff L; Jouve L; Melon C; Salin P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S167-70. PubMed ID: 20082982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat.
    Bacci JJ; Kerkerian-Le Goff L; Salin P
    Eur J Neurosci; 2002 Jun; 15(12):1918-28. PubMed ID: 12099898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of electrical stimulation of the parafascicular nucleus on the neuronal activities of the subthalamic nucleus and the ventromedial nucleus in rats].
    Lin FK; Xin Y; Gao DM; Xiong Z; Chen JG
    Sheng Li Xue Bao; 2007 Feb; 59(1):79-85. PubMed ID: 17294046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facing the lack of anti-phase oscillation in the parafascicular nucleus after dopamine depletion.
    Tseng KY
    Exp Neurol; 2009 Sep; 219(1):62-5. PubMed ID: 19501087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.
    Smith Y; Raju D; Nanda B; Pare JF; Galvan A; Wichmann T
    Brain Res Bull; 2009 Feb; 78(2-3):60-8. PubMed ID: 18805468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders.
    Benabid AL
    Brain Res Bull; 2009 Feb; 78(2-3):109-12. PubMed ID: 18812212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.
    Sgambato-Faure V; Cenci MA
    Prog Neurobiol; 2012 Jan; 96(1):69-86. PubMed ID: 22075179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.